Clinical Trials Browser

Phase 1/2 × Carcinoma, Ovarian Epithelial × pazopanib × Clear all

NCT01238770 2016-02-10

Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms